Clinical trial
Safety and Efficacy Study of RENEWAL 4 AVT
NCT00180336 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00180336 |
|---|---|
| Title | Safety and Efficacy Study of RENEWAL 4 AVT |
| Official title | CONTAK RENEWAL 4 AVT Field Following |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Tachycardia, Atrial Fibrillation, Atrial Flutter, Ventricular Fibrillation |
| Intervention type | Device |
| Interventions | CRT-D |
| Enrollment | 170 |
| Start date | Jul 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 25, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: